open access

Vol 59, No 3 (2008)
Original papers
Published online: 2008-05-08
Submitted: 2013-02-15
Get Citation

Ghrelin as a potential blood pressure reducing factor in obese women during weight loss treatment

Katarzyna Mizia-Stec, Barbara Zahorska-Markiewicz, Magdalena Olszanecka-Glinianowicz, Joanna Janowska, Zbigniew Mucha, Michał Holecki, Zbigniew Gąsior
Endokrynologia Polska 2008;59(3):207-211.

open access

Vol 59, No 3 (2008)
Original papers
Published online: 2008-05-08
Submitted: 2013-02-15

Abstract

Background: In animal models ghrelin reduces cardiac afterload and increases cardiac output via receptors in the cardiovascular system. The aim of our study was to evaluate a potential relationship between weight loss treatment, blood pressure and serum ghrelin concentrations in obese women.
Material and methods: A group of 37 obese premenopausal women with no previous history of hypertension (BMI: 36.5 ± 5 kg/m2) were involved in the study. Blood pressure and serum ghrelin levels were assessed before and after a three-month weight reduction treatment, which consisted of a diet of 1000 kcal/day and physical exercise. Body composition was determined by impedance analysis using Bodystat.
Results: Following weight loss (mean 8.9 &#177; 4.8 kg) SBP decreased (120 &#177; 13 vs. 115 &#177; 14 mm Hg, p = 0.01) and serum ghrelin levels increased significantly (66.9 &#177; 13.7 vs. 73.9 &#177; 15.4 pg/ml; p = 0.005). There were significant correlations between values for ghrelin levels after weight loss and SBP (r = -0.45, p = 0.02), DBP (r = -0.41, p < 0.05), and between Dghrelin levels and DSBP (r = 0.52, p = 0.006), DDBP (r = 0.53, p = 0.005). There was a positive correlation between an increase in ghrelin and a decrease in percentage body fat during weight loss (r = 0.51; p = 0.002).
Conclusion: The results seem to provide evidence that weight loss may decrease blood pressure in obese patients via a ghrelin-dependent mechanism.

Abstract

Background: In animal models ghrelin reduces cardiac afterload and increases cardiac output via receptors in the cardiovascular system. The aim of our study was to evaluate a potential relationship between weight loss treatment, blood pressure and serum ghrelin concentrations in obese women.
Material and methods: A group of 37 obese premenopausal women with no previous history of hypertension (BMI: 36.5 &#177; 5 kg/m2) were involved in the study. Blood pressure and serum ghrelin levels were assessed before and after a three-month weight reduction treatment, which consisted of a diet of 1000 kcal/day and physical exercise. Body composition was determined by impedance analysis using Bodystat.
Results: Following weight loss (mean 8.9 &#177; 4.8 kg) SBP decreased (120 &#177; 13 vs. 115 &#177; 14 mm Hg, p = 0.01) and serum ghrelin levels increased significantly (66.9 &#177; 13.7 vs. 73.9 &#177; 15.4 pg/ml; p = 0.005). There were significant correlations between values for ghrelin levels after weight loss and SBP (r = -0.45, p = 0.02), DBP (r = -0.41, p < 0.05), and between Dghrelin levels and DSBP (r = 0.52, p = 0.006), DDBP (r = 0.53, p = 0.005). There was a positive correlation between an increase in ghrelin and a decrease in percentage body fat during weight loss (r = 0.51; p = 0.002).
Conclusion: The results seem to provide evidence that weight loss may decrease blood pressure in obese patients via a ghrelin-dependent mechanism.
Get Citation

Keywords

obesity; ghrelin; arterial blood pressure; weight loss

About this article
Title

Ghrelin as a potential blood pressure reducing factor in obese women during weight loss treatment

Journal

Endokrynologia Polska

Issue

Vol 59, No 3 (2008)

Pages

207-211

Published online

2008-05-08

Bibliographic record

Endokrynologia Polska 2008;59(3):207-211.

Keywords

obesity
ghrelin
arterial blood pressure
weight loss

Authors

Katarzyna Mizia-Stec
Barbara Zahorska-Markiewicz
Magdalena Olszanecka-Glinianowicz
Joanna Janowska
Zbigniew Mucha
Michał Holecki
Zbigniew Gąsior

Important: This website uses cookies.tanya dokter More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl